Pragmatica-Lung Cancer Treatment Trial - NCI
WebPragmatica-Lung is a phase 3 clinical trial for people with non-small cell lung cancer that has spread beyond the lungs (stage 4 cancer). People in the trial will be assigned by chance (randomly) to receive either standard chemotherapy or a combination of the drugs ramucirumab (Cyramza) and pembrolizumab (Keytruda).
Lung Cancer Clinical Trials - Mayo Clinic Research
WebThe four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer.
Lung Cancer Clinical Trials & Research | Memorial Sloan …
WebThe following clinical trials for lung cancer are currently enrolling new patients. To learn more about a particular study, choose from the list below. For more information about any of our clinical trials, call us at 866-MSK-LUNG ( 866-675-5864 ), or talk with your doctor.
Lung Cancer Program - Clinical trials - Mayo Clinic
WebJul 18, 2023 · Below are current clinical trials. 22 studies in Lung Cancer Program (open studies only). Filter this list of studies by location, status and more. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) Albert Lea, Minn., Mankato, Minn.
Advances in Lung Cancer Research - NCI - National Cancer Institute
WebMay 8, 2024 · Learn what's new in lung cancer research through recent findings from studies that used immunotherapy and targeted therapies to treat lung cancer. Find how research efforts to detect lung cancer early are using blood and sputum samples and even artificial intelligence.
Clinical Trials | American Lung Association
WebMar 16, 2023 · Patients can search for clinical trials that match their specific diagnosis and treatment history. Also, join the Lung Cancer Registry, which may help match you with clinical trials that might be right for your type of lung cancer.
Lung-MAP Clinical Trial - NCI - National Cancer Institute
WebSep 24, 2020 · Lung-MAP, or the Lung Cancer Master Protocol, is a precision medicine clinical trial for people with advanced non-small cell lung cancer that has continued to grow after treatment. Non-small cell lung cancer makes up about 85% of lung cancer diagnoses.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
WebApr 11, 2022 · Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery alone for resectable non–small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-based neoadjuvant regimens ...
Understanding Clinical Trials for Lung Cancer
WebClinical trials are research studies that test new and promising treatments directly with patients. In fact, today’s gold standard treatment options were once studies in a clinical trial. These studies may also test new ways to prevent or diagnose diseases such as lung cancer.
Clinical Trials for Lung Cancer | LCRF
WebParticipating in a clinical trial may enable patients to access the newest lung cancer treatments before they are widely available. Patients in clinical trials also receive high-quality care, while helping researchers improve care for current and future cancer patients.
Skip to content